상세정보
- |Home >
- 상세정보
부가기능
CARDIOPULMONARY SUPPORT AND PHYSIOLOGY - Aprotinin administration in the pericardial cavity does not prevent platelet activation - In a double-blind placebo-controlled study of 13 patients, we demonstrated that administration of aprotinin into the pericardial cavity during CPB, at concentrations similar to the dosage used for its systemic application, does not inhibit the reduction of platelet surface GPIb expression or the formation of microparticles or platelet complexes/
기사 상세정보
소장정보
- 소장정보
| No. | 권호·제본정보 보기 | 소장처 | 소장사항 | 청구기호 | 구독 | 최근입수호 |
|---|---|---|---|---|---|---|
| 1 | 의학도서관/연속간행물/ | 617.54 J86a | 구독중단 | Vol.144 no.6 |
하단메뉴
